CSF-1 and its receptor in ovarian, endometrial and breast cancer (Q40520354)

21 September 2017

1 reference

title

CSF-1 and its receptor in ovarian, endometrial and breast cancer (English)

1 reference

21 September 2017

Kacinski BM

1

1 reference

PubMed ID

7742005

21 September 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

21 September 2017

1 reference

21 September 2017

27

1 reference

21 September 2017

1

1 reference

21 September 2017

79-85

1 reference

21 September 2017

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

The human hematopoietic colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Expression of the human c-fms proto-oncogene product (colony-stimulating factor-1 receptor) on peripheral blood mononuclear cells and choriocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Apparent role of the macrophage growth factor, CSF-1, in placental development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

A pregnancy defect in the osteopetrotic () mouse demonstrates the requirement for CSF-1 in female fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Urokinase plasminogen activator and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

CSF-1 and C-FMS gene expression in human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

The first intron of human c-fms proto-oncogene contains a processed pseudogene (RPL7P) for ribosomal protein L7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Origins of human cancer revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF). Induction by granulocyte/macrophage CSF and inhibition by CSF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899509031941

10.3109/07853899509031941

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7742005